ProKidney Corp. (PROK) Misses Q3 EPS by 2c

ProKidney Corp. (NASDAQ: PROK) reported Q3 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on ProKidney Corp. (PROK) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'